Dermatologic infections in cancer patients

Cancer Treatment and Research

Volumn 161, Issue , 2014, Pages 299-317

  Gandhi, Mona ^a   Brieva, Joaquin C ^b   Lacouture, Mario E ^c  

^a Jr Hospital of Cook County   (United States)

^b Kovler Organ Transplantation Center NMH Arkes Family Pavilion   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anti cancer therapy; Bacterial dermatologic infection; Cutaneous infection; Dermatoxicity; Fungal dermatologic infection; Secondary infection; Therapy related infection; Viral dermatologic infection

Indexed keywords

BORTEZOMIB; RITUXIMAB; DERMATOLOGICAL AGENT;

ACANTHAMOEBA INFECTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CELLULITIS; COMORBIDITY; CORYNEBACTERIUM INFECTION; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HIDRADENITIS; HUMAN; LYMPHEDEMA; NEUTROPHILIC ECCRINE HIDRADENITIS; OPPORTUNISTIC INFECTION; PHAEOHYPHOMYCOSIS; PRIORITY JOURNAL; SKIN CANDIDIASIS; SKIN FLORA; SKIN INFECTION; SKIN ULCER; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; STENOTROPHOMONAS MALTOPHILIA; TOXOPLASMOSIS; WOUND INFECTION; MICROBIOLOGY; MYCOSIS; NEOPLASM; REVIEW; RISK FACTOR;

DERMATOLOGIC AGENTS; HUMANS; MYCOSES; NEOPLASMS; RISK FACTORS; SKIN DISEASES, INFECTIOUS;

EID: 84902094383     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-319-04220-6_10     Document Type: Article

References (55)

1. Polsky B, Armstrong D (1985) Infectious complications of neoplastic disease. Am J Infect Control 13(5): 199-209.
2. Trilla A, Miro JM (1995) Identifying high risk patients for Staphylococcus aureus infections: Skin and soft tissue infections. J Chemother 7(3): 37-43.
3. Miller LG, Kaplan SL (2009) Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am 23(1): 35-52.
4. Carney DN, Fossieck BE Jr, Parker RH, Minna JD (1982) Bacteremia due to Staphylococcus aureus in patients with cancer: report on 45 cases in adults and review of the literature. Rev Infect Dis 4(1): 1-12.
5. Scheinpflug K, Schalk E, Mohren M (2008) Staphylococcal scalded skin syndrome in an adult patient with T-lymphoblastic non-Hodgkin's lymphoma. Onkologie 31(11): 616-619 Epub 2008 Oct 27.
6. Mihu CN, Schaub J, Kesh S, Jakubowski A et al (2008) Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a singleinstitution, nested case-controlled study. Biol Blood Marrow Transplant 14(12): 1429-1433.
7. Talpur R, Bassett R, Duvic M (2008) Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sezary syndrome. Br J Dermatol 159(1): 105-112 Epub 2008 Jul 1.
8. Nguyen V, Huggins R, Lertsburapa T, Bauer K et al (2008) Cutaneous T-cell lymphoma and Staphylococcus aureus colonization. J Am Acad Dermatol 59(6): 949-952 Epub 2008 Oct 2.
9. Tsambiras PE, Patel S, Greene J et al (2001) Infectious complications of cutaneous T-cell lymphoma. Cancer Control 8: 185-188.
10. Frassetto LA (2009) Corynebacterium Infections. http://emedicine. medscape. com/article/215100-overview. 22 April 2009.
11. Adderson EE, Boudreaux JW, Hayden RT (2008) Infections caused by coryneform bacteria in pediatric oncology patients. Pediatr Infect Dis J 27(2): 136-141.
12. Ashour HM, El-Sharif A (2009) Species distribution and antimicrobial susceptibility of gramnegative aerobic bacteria in hospitalized cancer patients. J Transl Med 19(7): 14.
13. Combemale P, Faisant M, Azoulay-Petit C, Dupin M et al (2000) Neutrophilic eccrine hidradenitis secondary to infection with Serratia marcescens. Br J Dermatol 142(4): 784-788.
14. Teo WY, Chan MY, Lam CM, Chong CY (2006) Skin manifestation of Stenotrophomonas maltophilia infection-a case report and review article. Ann Acad Med Singapore 35(12): 897-900.
15. Moser C, Jonsson V, Thomsen K, Albrectsen J et al (1997) Subcutaneous lesions and bacteremia due to Stenotrophomonas maltophilia in three leukemic patients with neutropenia. Br J Dermatol 136: 949-952.
16. Mays SR, Bogle MA, Bodey GP (2006) Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol 7(1): 31-43.
17. Quatresooz P, Piérard-Franchimont C, Arrese JE et al (2008) Clinicopathologic presentations of dermatomycoses in cancer patients. J Eur Acad Dermatol Venereol 22(8): 907-917 Epub 2008 May 23.
18. Nucci M, Pulcheri W, Spector N et al (1992) Cutaneous involvement of systemic fungal infections in neutropenic patients. Haematologica 77(6): 522-523.
19. Gugic D, Cleary T, Vincek V (2008) Candida glabrata infection in gastric carcinoma patient mimicking cutaneous histoplasmosis. Dermatol Online J 14(2): 15.
20. Devirgiliis V, Panasiti V, Borroni RG, Rossi M et al (2008) Cutaneous cryptococcosis in a patient affected by chronic lymphocytic leukaemia: a case report. Int J Immunopathol Pharmacol 21(2): 463-466.
21. Courville P, Favennec L, Viacroze C, Barrel A et al (2002) Co-existent cutaneous cryptococcosis of the forearm and cutaneous alternariosis of the leg in patient with metastatic thymoma. J Cutan Pathol 29(1): 55-58.
22. D'Antonio D, Pagano L, Girmenia C et al (2000) Cutaneous aspergillosis in patients with haematological malignancies. Eur J Clin Microbiol Infect Dis 19(5): 362-365.
23. Bodey GP, Boktour M, Mays S et al (2002) Skin lesions associated with Fusarium infection. J Am Acad Dermatol 47(5): 659-666.
24. Musa MO, Al Eisa A, Halim M et al (2000) The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immuno compromised patients: a single institution experience over 10 years. Br J Haematol 108(3): 544-548.
25. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP (2009) Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 48(8): 1033-1041.
26. Boeckh M, Kim HM, Flowers MED, Meyers JD et al (2006) Long-term acyclovir for prevention of varicella zoster virus disease after allogenic hematopoietic cell transplantationa radndomized double-blind placebo-controlled study Blood. 107(5): 1800-1805.
27. Angarone M, Ison MG (2008) Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients. J Natl Compr Canc Netw 6(2): 191-201.
28. Rusthoven JJ, Ahlgren P, Elhakim T et al (1988) Varicella-zoster infection in adult cancer patients. A Popul Study Arch Intern Med 148(7): 1561-1566.
29. Han CS, Miller W, Haake R et al (1994) Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 13(3): 277-283.
30. Niscola P, Perrotti AP, del Poeta G et al (2007) Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures. Herpes 14(2): 45-47.
31. Abdull Gaffar B, Raman LG, Al Muala A (2008) Cutaneous cytomegalovirus infection in a patient with acquired immunodeficiency syndrome. Int J Dermatol 47(9): 944-946.
32. Amir G, Salant H, Resnick IB, Karplus R (2008) Cutaneous toxoplasmosis after bone marrow transplantation with molecular confirmation. J Am Acad Dermatol 59(5): 781-784 Epub 2008 Aug 23.
33. Kaul DR, Lowe L, Visvesvara GS, Farmen S et al (2008) Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transpl Infect Dis 10(6): 437-441 Epub 2008 Aug 13.
34. Boone SL, Rademaker A, Liu D et al (2007) Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology. 72(3-4): 152-159 Epub 2007 Dec 21.
35. Eilers RE, West DP, Ortiz S, Witherspoon JN, Lacouture ME (2009) Dermatologic infections complicate epidermal growth factor receptor inhibitor (EGFRI) therapy in cancer patients. J Am Acad Dermatol, 60(3)(Suppl 1): AB3.
36. Chanan-Khan A, Sonneveld P, Schuster MW et al (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncol 26(29): 4784-4790 Epub 2008 Aug 18.
37. Vickrey E, Allen S, Mehta J et al (2009) Acyclovir to prevent reactivation of varicella zoster virus (herpes zoster) in multiple myeloma patients receiving bortezomib therapy. Cancer 115(1): 229-232.
38. Aksoy S, Harputluoglu H, Kilickap S et al (2007) Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma 48(7): 1307-1312.
39. Schwarzberg AB, Stover EH, Sengupta T et al (2007) Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest 25(4): 249-255.
40. Au WY, Kwong YL (2005) Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge. J Am Acad Dermatol 53(5): 890-892.
41. Khan SA, Wingard JR (2001) Infection and mucosal injury in cancer treatment. J Natl Cancer Inst Monogr 29: 31-36.
42. Brook I (1988) Use of antibiotics in the management of postirradiation wound infection and sepsis. Radiat Res 115(1): 1-25.
43. Hughes LL, Styblo TM, Thoms WW et al (1997) Cellulitis of the breast as a complication of breast-conserving surgery and irradiation. Am J Clin Oncol 20(4): 338-341.
44. Mak SS, Yuen ML, Li C et al (2006) Exploratory analysis of the bacteriological status of post-irradiation wounds and its relationship to healing. Clin Oncol R Coll Radiol 18(7): 519-524.
45. Johnson LB, Jorgensen LN, Adawi D et al (2005) The effect of preoperative radiotherapy on systemic collagen deposition and postoperative infective complications in rectal cancer patients. Dis Colon Rectum 48(8): 1573-1580.
46. Hill A, Hanson M, Bogle MA et al (2004) Severe radiation dermatitis is related to Staphylococcus aureus. Am J Clin Oncol 27(4): 361-363.
47. Smith BD, Son CB, Wilson LD (2003) Disseminated herpes simplex after total skin electron beam radiotherapy for mycosis fungoides. J R Soc Med 96(10): 500-501.
48. McGregor DH, Yang Q, Fan F et al (2001) Scabies associated with radiation therapy for cutaneous T-cell lymphoma. Ann Clin Lab Sci 31(1): 103-107.
49. Shih YC, Xu Y, Cormier JN, Giordano S et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27(12): 2007-2014 Epub 2009 Mar 16.
50. Vignes S, Dupay A (2006) Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. J Eur Acad Dermatol Venereol 20(7): 818-822.
51. Masmoudi A, Maaloul I, Turki H, Elloumi Y et al (2005) Erysipelas after breast cancer treatment 26 cases. Dermatol Online J 11(3): 12.
52. Laurenzi L, Natoli S, Benedetti C et al (2004) Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices. Support Care Cancer 12(11): 805-809.
53. Schwarz RE, Groeger JS, Coit DG (1997) Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79(8): 1635-1640.
54. Ballarini C, Intra M, Pisani Ceretti A et al (1999) Complications of subcutaneous infusion port in the general oncology population. Oncology. 56(2): 97-102.
55. Brothers TE, Von Moll LK, Niederhuber JE et al (1988) Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 166: 295-301.